Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Merck CEO Frazier to testify at Senate drug pricing hearing

      Merck CEO Frazier to testify at Senate drug pricing hearing

      Farhat Nasim6 Feb 2019 9:05 AM IST
      Republican Senator Chuck Grassley, chairman of the Senate Finance Committee, and Democratic Senator Ron Wyden, ranking member of the committee, on...
      FDA nod to cheaper Botox rival to treat frown lines

      FDA nod to cheaper Botox rival to treat frown lines

      Farhat Nasim5 Feb 2019 9:00 AM IST
      Botox was launched in 2002 and over the years it has evolved from a cosmetic injection to a treatment for migraines and bladder dysfunction, bringing...
      Narayana Hrudayalaya MD-Group CEO Ashutosh Raghuvanshi resigns

      Narayana Hrudayalaya MD-Group CEO Ashutosh Raghuvanshi resigns

      Farhat Nasim4 Feb 2019 10:00 AM IST
      Dr Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO of Narayana Hrudayalaya Ltd has tendered his resignation.Mumbai: Private...
      Lupin recalls over 24000 bottles of Fluocinolone Acetonide topical solution from US

      Lupin recalls over 24000 bottles of Fluocinolone Acetonide topical solution from US

      Farhat Nasim4 Feb 2019 9:45 AM IST
      New Delhi: Mumbai based drug firm Lupin is recalling from the US and Puerto Rico over 24 thousand bottles of Fluocinolone Acetonide topical solution...
      Laurus Labs gets tentative USFDA approval for HIV combo drug

      Laurus Labs gets tentative USFDA approval for HIV combo drug

      Farhat Nasim4 Feb 2019 9:30 AM IST
      Hyderabad: Indian pharmaceutical player, Laurus Labs said Sunday it has received tentative approval from the United States Food and Drug...
      Lupin launches NaMuscla in Germany and UK for treating Myotonic Disorders

      Lupin launches NaMuscla in Germany and UK for treating Myotonic Disorders

      Farhat Nasim3 Feb 2019 9:30 AM IST
      Lupin has ongoing partnering discussions for the commercialization of NaMuscla in European territories outside of Germany and the UK.Mumbai: As stated...
      Israeli company claims to have found 100 percent cure for cancer

      Israeli company claims to have found 100 percent cure for cancer

      Farhat Nasim2 Feb 2019 4:06 PM IST
      "Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost...
      FDA approves generic of Advair Diskus for asthma

      FDA approves generic of Advair Diskus for asthma

      Farhat Nasim2 Feb 2019 9:00 AM IST
      U.S: The U.S. Food and Drug Administration recently approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation...
      How to Dispose off Expired, Unused drugs- Indian Pharmaceutical Association asks Nadda

      How to Dispose off Expired, Unused drugs- Indian Pharmaceutical Association asks Nadda

      Farhat Nasim1 Feb 2019 3:22 PM IST
      New Delhi: In an attempt to draw the government's attention towards a major concern towards lack of protocols as well as awareness regarding the...
      AGRA: CDSCO issues notice to 72 drug stores for selling prohibited drugs

      AGRA: CDSCO issues notice to 72 drug stores for selling prohibited drugs

      Farhat Nasim1 Feb 2019 2:43 PM IST
      AGRA: In order to tighten the noose and track the network of illegal drug business allegedly taking place in Agra region for several months, the...
      Natco Pharma submits new drug application with USFDA for generic Ibrutinib tablets

      Natco Pharma submits new drug application with USFDA for generic Ibrutinib tablets

      Farhat Nasim1 Feb 2019 9:30 AM IST
      Natco has submitted the application with the US Food and Drug Administration(USFDA) for a generic version of Ibrutinib tablets in the strengths of 140...
      Thailand: Three Companies try to patent medical marijuana, applications suspended

      Thailand: Three Companies try to patent medical marijuana, applications suspended

      Farhat Nasim1 Feb 2019 9:25 AM IST
      Bangkok: Thailand's military government on Monday suspended the licensing of commercial marijuana-based products for medical use amid concern that...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok